NCT03331770View on ClinicalTrials.gov

Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost

PHASE4CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

January 6, 2017

Primary Completion Date

October 6, 2017

Study Completion Date

October 6, 2017

Conditions
Primary Open-angle Glaucoma
Interventions
DRUG

Latanoprost Ophthalmic Product

Multidose bottle, preserved with potassium sorbate, that can be stored at room temperature up to 30°C during all shelf life, the emulsion does not require shaking before use

Trial Locations (1)

1407

Laboratoarios Poen, Buenos Aires

Sponsors

Lead Sponsor

Laboratorios Poen
All Listed Sponsors
lead

Laboratorios Poen

INDUSTRY